Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CCXI $5.20 0.7800 +17.65%
STML $7.81 1.0200 +15.02%
OMED $14.62 1.0400 +7.66%
ARGS $5.96 0.4000 +7.19%
TGTX $7.73 0.5100 +7.06%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

VRML $1.21 -0.0900 -6.92%
GTXI $0.72 -0.0300 -4.00%
TKMR $4.10 -0.1600 -3.76%
MACK $6.31 -0.2300 -3.52%
IMDZ $12.56 -0.3800 -2.94%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

Alzheimer’s Disease May Stem From Infections

(TIME) May 26, 2016 - A provocative new study suggests Alzheimer's disease may stem from the brain fighting off infections.
read article 

Sanofi Wins FDA Panel’s Backing for Once-Daily Diabetes Combo

(Bloomberg) May 25, 2016 - Sanofi’s once-a-day shot for diabetes that combines two drugs should be approved for sale, a group of advisers to the U.S. Food and Drug Administration said.
read article 

BIO Releases Largest Study Ever on Clinical Development Success Rates

(BIO) May 25, 2016 - Use of biomarkers as selection criteria found to dramatically increase success rates.
read press release 

Radiation Oncologists Meet With Members of Congress to Advocate for Sustained Increases to Cancer Research Funding

(Yahoo! Finance) May 25, 2016 - Radiation oncologists from across the United States convened on Capitol Hill yesterday to encourage members of Congress to invest in cancer research with sustainable and predictable funding and to protect patients' access to high quality cancer care through value-based physician payment models.
read article 

Free Colonoscopy Program for Uninsured At-Risk Patients Detects Cancer at an Earlier Stage and is Cost Neutral

(American College of Surgeons) May 26, 2016 - For uninsured patients who are at a high risk for colorectal cancer (CRC), performing free screening colonoscopies can identify cancer at an earlier stage and appears to be cost neutral from a hospital system perspective, according to study results published online in the Journal of the American College of Surgeons ahead of print publication.
read press release 

DelMar Pharmaceuticals Announces Successful Completion of End-of-Phase 2 Meeting with FDA on VAL-083 for the Treatment of Refractory Glioblastoma Multiforme

(Yahoo! Finance) May 25, 2016 - DelMar Pharmaceuticals, Inc, a company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced the successful completion of an End of Phase 2 meeting with the U.S. Food and Drug Administration (FDA).
read article 

Cigna Issues Positive Coverage Decision for NanoString's Prosigna® Breast Cancer Assay

(Financial Content) May 26, 2016 - NanoString Technologies, Inc. today announced that Cigna has issued a positive Medical Coverage Policy decision for the Prosigna® Breast Cancer Gene Signature Assay.
read article 

QIAGEN Partners to Develop Predictive Tests in Oncology

(QIAGEN) May 25, 2016 – An initial project will be to develop and market PITX2 as a marker to predict effectiveness of anthracycline treatment in triple negative and other high-risk breast cancer patients.
read corporate press release 

Guardant Health Announces Project LUNAR, An Ambitious Multi-arm, Multi-site Umbrella Trial to Study Blood Test for Early Cancer Detection

(Yahoo! Finance) May 26, 2016 - Guardant Health announced today the launch of an ambitious initiative, Project LUNAR, which will extend the technology behind the company's market-leading comprehensive liquid biopsy, Guardant360, into early-stage cancer detection.
read article 

House Democrats Blast US Trade Rep For Pressuring Colombia Over Novartis Patent

(STAT/Pharmalot) May 25, 2016 - A group of 15 House Democrats wants United States Trade Representative Michael Froman to explain why his office appeared to pressure Colombia not to sidestep a patent on a Novartis cancer drug.
read article 

Pfizer Offers Hope For Lower-Priced Cancer Drug Combos

(Forbes) May 26, 2016 - Speaking at the UBS Healthcare Conference, Ms. Liz Barrett, Pfizer's Global President and General Manager of Oncology, hit the challenge of cancer drug pricing head on.
read article 

How to Define Value: Patient Outcomes or Modeling?

(BMS) May 26, 2016 - Bristol-Myers Squibb's response to ICER's report,"Treatment Options for Relapsed or Refractory Multiple Myeloma: Effectiveness, Value, and Value-based Price Benchmarks."
read corporate press release 

Pathway Genomics Provides Updates for CancerIntercept™ Detect Clinical Program

(Pathway Genomics) May 26, 2016 - Three clinical investigations now enrolling with the initiation of new study in thyroid cancer detection; two abstracts published in 2016 ASCO annual meeting proceedings.
read corporate press release 

AVEO Announces Dosing of First Patient in the Pivotal Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma

(Stockhouse) May 26,2016 - AVEO Oncology today announced that the first patient has been dosed in the Company's pivotal TIVO-3 trial, a randomized, controlled, multi-center, open-label study to compare tivozanib to sorafenib in subjects with refractory advanced renal cell carcinoma (RCC).
read article 

Bone Marrow Transplant Success Depends on the Dose

(Genetic Engineering & Biotechnology News) May 26, 2016 - Scientists from the University of Southern California say they have found clues about how the dose of transplanted bone marrow might affect patients undergoing this risky procedure, frequently used to treat cancer and blood diseases.
read article (free registration required) 

Adults With Previous Nonmelanoma Skin Cancer More Likely To Use Sun Protection, But Still Sunburn

(Healio) May 25, 2016 - While adults with previous nonmelanoma skin cancer were more likely to practice sun protection compared with people without a history of skin cancer, they reported similar relative odds of recent sunburn, according to published study results.
read article 

Cleveland Researchers Developing GPS For Rectal Cancer Surgery

(CWRU/Think) May 25, 2016 - Researchers estimate that up to 10,000 rectal cancer patients undergo unnecessary surgery, and more than 25,000 suffer from pelvic sepsis, wound infection and permanent impairments from aggressive surgery in the United States annually.
read press release  

Differences in Metabolism between Androgen-Dependent and Castration Resistant Prostate Cancer May Lead to New Therapies

(Baylor College of Medicine) May 19, 2016 - Researchers from Baylor College of Medicine and University of Michigan, along with collaborators in other institutions, have determined that castration resistant prostate cancer (CRPC) has particular metabolic characteristics that may open new possibilities for treatment.
read article 

Scientists Block Breast Cancer Cells From Hiding in Bones

(Duke Medicine) May 25, 2016 - Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise eradicate them.
read press release 

Filling In The 'Missing Biology' Of Breast Cancer

(Fred Hutch News Service) May 25, 2016 - The first large-scale study of its kind in breast cancer, the research demonstrates how proteomics, or studying all the proteins in a given cell, can reveal which of the many mutations in a tumor are actually driving a cancer's development and suggest new targets for personalized cancer-killing drugs.
read article 

Researchers Find 8 Immune Genes in Aggressive Brain Cancer

(U.S. News & World Report/HealthDay News) May 25, 2016 - Researchers have identified immune genes that may affect how long people live after diagnosis with a common type of brain cancer.
read article 

Study Raises Questions FDA Standards On New Cancer Drugs

(Milwaukee Journal Sentinel) May 26, 2016 - A new study has called into question the standards used by the U.S. Food and Drug Administration to approve new cancer drugs and whether those drugs are helping patients live longer.
read article 

Lung Cancer Patients at Bigger Cancer Centers May Have Better Outcomes

(Reuters Health) May 25, 2016 - Lung cancer patients getting radiation at hospitals with higher rates of participation in a clinical trial fared significantly better compared to those at centers with low participation, U.S. researchers say.
read article 

Financial Crisis Caused 500,000 Extra Cancer Deaths, According to Lancet Study

(The Telegraph/Agence France-Presse [UK]) May 26, 2016 - The global financial crisis may have caused an additional 500,000 cancer deaths from 2008 to 2010, according to a new study, with patients locked out of treatment because of unemployment and healthcare cuts.
read article 

U.S. FDA Panel Recommends Approval Of Novo Nordisk Diabetes Drug

(Reuters) May 25, 2016 - A U.S. advisory panel on Tuesday recommended approval of a new diabetes drug made by Novo Nordisk A/S that combines two of its existing treatments in a fixed-dose combination designed to be both effective and convenient.
read article